Management and Novel Adjuncts of Necrotizing Soft Tissue Infections

Christine S Cocanour, Phillip Chang, Jared M. Huston, Charles A. Adams, Jose J. Diaz, Charles B. Wessel, Bonnie A. Falcione, Graciela M. Bauza, Raquel A. Forsythe, Matthew R. Rosengart

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Necrotizing soft tissue infections (NSTI) have been recognized for millennia and continue to impose considerable burden on both patient and society in terms of morbidity, death, and the allocation of resources. With improvements in the delivery of critical care, outcomes have improved, although disease-specific therapies are lacking. The basic principles of early diagnosis, of prompt and broad antimicrobial therapy, and of aggressive debridement have remained unchanged. Clearly novel and new therapeutics are needed to combat this persistently lethal disease. This review emphasizes the pillars of NSTI management and then summarizes the contemporary evidence supporting the incorporation of novel adjuncts to the pharmacologic and operative foundations of managing this disease.

Original languageEnglish (US)
Pages (from-to)250-272
Number of pages23
JournalSurgical Infections
Volume18
Issue number3
DOIs
StatePublished - Apr 1 2017
Externally publishedYes

Fingerprint

Soft Tissue Infections
Resource Allocation
Debridement
Early Diagnosis
Therapeutics
Morbidity

Keywords

  • necrotizing fasciitis
  • necrotizing soft tissue infection
  • sepsis

ASJC Scopus subject areas

  • Surgery
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Cocanour, C. S., Chang, P., Huston, J. M., Adams, C. A., Diaz, J. J., Wessel, C. B., ... Rosengart, M. R. (2017). Management and Novel Adjuncts of Necrotizing Soft Tissue Infections. Surgical Infections, 18(3), 250-272. https://doi.org/10.1089/sur.2016.200

Management and Novel Adjuncts of Necrotizing Soft Tissue Infections. / Cocanour, Christine S; Chang, Phillip; Huston, Jared M.; Adams, Charles A.; Diaz, Jose J.; Wessel, Charles B.; Falcione, Bonnie A.; Bauza, Graciela M.; Forsythe, Raquel A.; Rosengart, Matthew R.

In: Surgical Infections, Vol. 18, No. 3, 01.04.2017, p. 250-272.

Research output: Contribution to journalReview article

Cocanour, CS, Chang, P, Huston, JM, Adams, CA, Diaz, JJ, Wessel, CB, Falcione, BA, Bauza, GM, Forsythe, RA & Rosengart, MR 2017, 'Management and Novel Adjuncts of Necrotizing Soft Tissue Infections', Surgical Infections, vol. 18, no. 3, pp. 250-272. https://doi.org/10.1089/sur.2016.200
Cocanour, Christine S ; Chang, Phillip ; Huston, Jared M. ; Adams, Charles A. ; Diaz, Jose J. ; Wessel, Charles B. ; Falcione, Bonnie A. ; Bauza, Graciela M. ; Forsythe, Raquel A. ; Rosengart, Matthew R. / Management and Novel Adjuncts of Necrotizing Soft Tissue Infections. In: Surgical Infections. 2017 ; Vol. 18, No. 3. pp. 250-272.
@article{f0369fc0fef44b6bafc6272d33d567d0,
title = "Management and Novel Adjuncts of Necrotizing Soft Tissue Infections",
abstract = "Necrotizing soft tissue infections (NSTI) have been recognized for millennia and continue to impose considerable burden on both patient and society in terms of morbidity, death, and the allocation of resources. With improvements in the delivery of critical care, outcomes have improved, although disease-specific therapies are lacking. The basic principles of early diagnosis, of prompt and broad antimicrobial therapy, and of aggressive debridement have remained unchanged. Clearly novel and new therapeutics are needed to combat this persistently lethal disease. This review emphasizes the pillars of NSTI management and then summarizes the contemporary evidence supporting the incorporation of novel adjuncts to the pharmacologic and operative foundations of managing this disease.",
keywords = "necrotizing fasciitis, necrotizing soft tissue infection, sepsis",
author = "Cocanour, {Christine S} and Phillip Chang and Huston, {Jared M.} and Adams, {Charles A.} and Diaz, {Jose J.} and Wessel, {Charles B.} and Falcione, {Bonnie A.} and Bauza, {Graciela M.} and Forsythe, {Raquel A.} and Rosengart, {Matthew R.}",
year = "2017",
month = "4",
day = "1",
doi = "10.1089/sur.2016.200",
language = "English (US)",
volume = "18",
pages = "250--272",
journal = "Surgical Infections",
issn = "1096-2964",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Management and Novel Adjuncts of Necrotizing Soft Tissue Infections

AU - Cocanour, Christine S

AU - Chang, Phillip

AU - Huston, Jared M.

AU - Adams, Charles A.

AU - Diaz, Jose J.

AU - Wessel, Charles B.

AU - Falcione, Bonnie A.

AU - Bauza, Graciela M.

AU - Forsythe, Raquel A.

AU - Rosengart, Matthew R.

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Necrotizing soft tissue infections (NSTI) have been recognized for millennia and continue to impose considerable burden on both patient and society in terms of morbidity, death, and the allocation of resources. With improvements in the delivery of critical care, outcomes have improved, although disease-specific therapies are lacking. The basic principles of early diagnosis, of prompt and broad antimicrobial therapy, and of aggressive debridement have remained unchanged. Clearly novel and new therapeutics are needed to combat this persistently lethal disease. This review emphasizes the pillars of NSTI management and then summarizes the contemporary evidence supporting the incorporation of novel adjuncts to the pharmacologic and operative foundations of managing this disease.

AB - Necrotizing soft tissue infections (NSTI) have been recognized for millennia and continue to impose considerable burden on both patient and society in terms of morbidity, death, and the allocation of resources. With improvements in the delivery of critical care, outcomes have improved, although disease-specific therapies are lacking. The basic principles of early diagnosis, of prompt and broad antimicrobial therapy, and of aggressive debridement have remained unchanged. Clearly novel and new therapeutics are needed to combat this persistently lethal disease. This review emphasizes the pillars of NSTI management and then summarizes the contemporary evidence supporting the incorporation of novel adjuncts to the pharmacologic and operative foundations of managing this disease.

KW - necrotizing fasciitis

KW - necrotizing soft tissue infection

KW - sepsis

UR - http://www.scopus.com/inward/record.url?scp=85017342937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017342937&partnerID=8YFLogxK

U2 - 10.1089/sur.2016.200

DO - 10.1089/sur.2016.200

M3 - Review article

C2 - 28375805

AN - SCOPUS:85017342937

VL - 18

SP - 250

EP - 272

JO - Surgical Infections

JF - Surgical Infections

SN - 1096-2964

IS - 3

ER -